Manhattan Scientifics, Inc.

MHTX

US5631221000

Entertainment Production

Delayed OTC Markets Other stock markets 08:13:39 20/05/2024 pm IST			5-day change	1st Jan Change
0.0014 ^USD	0.00%		+40.00%	-46.15%

10/04	Manhattan Scientifics, Inc Announces Resignation of Frank Georgiou as Member of the Board of Directors	CI
02/04	Manhattan Scientifics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	CI

Manhattan Scientifics, Inc. Reports Earnings Results for the Second Quarter Ended June 30, 2020

August 20, 2020 at 03:02 am IST

Manhattan Scientifics, Inc. announced earnings results for the second quarter ended June 30, 2020. For the second quarter, the company announced sales was USD 50,000 compared to USD 50,000 a year ago. Net income was USD 528,000 compared to net loss of USD 908,000 a year ago. For the half year, sales was USD 50,000 compared to USD 50,000 a year ago. Net loss was USD 204,000 compared to USD 1.344 million a year ago.

Latest news about Manhattan Scientifics, Inc.

Manhattan Scientifics, Inc Announces Resignation of Frank Georgiou as Member of the Board of Directors	11/04	CI
Manhattan Scientifics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	02/04	CI
Manhattan Scientifics, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	21/11	CI
Manhattan Scientifics, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	22/23/22	CI
Manhattan Scientifics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023	23/23/23	CI
Manhattan Scientifics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2022	14/23/14	CI
Manhattan Scientifics, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	15/22/15	CI
Manhattan Scientifics, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	16/22/16	CI
Manhattan Scientifics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2022	16/22/16	CI
Manhattan Scientifics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2021	06/22/06	CI
Manhattan Scientifics, Inc. Auditor Raises 'Going Concern' Doubt	06/22/06	CI
Manhattan Scientifics, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021	16/21/16	CI
Manhattan Scientifics, Inc. Reports Earnings Results for the Second Quarter Ended June 30, 2021	23/21/23	CI
Manhattan Scientifics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2021	17/21/17	CI
Manhattan Scientifics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2020	16/21/16	CI
Manhattan Scientifics, Inc. Reports Earnings Results for the Third Quarter Ended September 30, 2020	17/20/17	CI
Manhattan Scientifics, Inc. Reports Earnings Results for the Second Quarter Ended June 30, 2020	20/20/20	CI
Manhattan Scientifics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2020	21/20/21	CI
Manhattan Scientifics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2019	15/20/15	CI
Manhattan Scientifics, Inc. Reports Earnings Results for the Third Quarter Ended September 30, 2019	20/19/20	CI
Manhattan Scientifics, Inc. Reports Earnings Results for the Second Quarter Ended June 30, 2019	20/19/20	CI
Manhattan Scientifics Announces Breakthrough Device for Detection of Cancer	19/19/19	CI
Manhattan Scientifics To Seek Acquisition	09/19/09	CI
Manhattan Scientifics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2019	21/19/21	CI
Manhattan Scientifics, Inc., and Metallicum, Inc. Enters into an Overarching Agreement with a Non-Affiliated Third Party	08/19/08	CI

Chart Manhattan Scientifics, Inc.

Duration

Period

More charts

Company Profile

Manhattan Scientifics, Inc. is focused on technology transfer and commercialization of these transformative technologies. The Company operates as a technology incubator. Its business model is to identify significant technologies; acquire them or the rights to them; secure the services of inventors, engineers or other staff who were instrumental in their creation; provide or contract for suitable work facilities, laboratories, and other aids where appropriate; prototype the technologies to demonstrate proof of principle feasibility; secure patent and or other intellectual property protection; secure early customers for product trials where feasible and appropriate; and commercialize through licenses, sales or cooperative efforts with other manufacturing and distribution firms. Its business model is based on licensing metals technology to metals manufacturers. Its technologies are in a development phase.

Sector

Entertainment Production

More about the company

Income Statement Evolution

More financial data

Sector Copyright Management

	1st Jan change	Capi.
MANHATTAN SCIENTIFICS, INC.	-46.15%	783K
DIVERSIFIED ROYALTY CORP.	+2.56%	339M
QANTM INTELLECTUAL PROPERTY LIMITED	+89.47%	170M
B.DUCK SEMK HOLDINGS INTERNATIONAL LIMITED	-12.98%	143M
PENDRELL CORPORATION	-.--%	139M
KUKE MUSIC HOLDING LIMITED	+191.46%	113M
NEXTONE INC.	+44.85%	94.83M
RESEARCH FRONTIERS INCORPORATED	+92.08%	64.35M